Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways

Biochemistry

Volumn 42, Issue 24, 2003, Pages 7561-7570

  Wu, Wei ^a   Coss, Djurdjica ^a   Lorenson, Mary Y ^a   Kuo, C Benson ^a   Xu, Xiaolei ^a   Walker, Ameae M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORYLATION;

ACTIVATION ANALYSIS; AMINO ACIDS; CELLS; GENETIC ENGINEERING; RNA;

GENES;

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA CASEIN; HYDROCORTISONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEAR PROTEIN; PHOSPHOAMINO ACID; PROLACTIN; PROTEIN JAK 2; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FLAVONOIDS; JANUS KINASE 2; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR MIMICRY; PHOSPHORYLATION; PROLACTIN; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, PROLACTIN; SERINE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYROSINE;

ANIMALIA;

EID: 0038408583     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034217s     Document Type: Article

References (39)

1. Kuo, C. B., Wu, W., Xu, X., Yang, L., Chen, C., Coss, D., Birdsall, B., Nasseri, D., and Walker, A. M. (2002) Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes β-casein gene expression in the rat mammary gland, Cell Tissue Res. 309, 429-437.
2. Coss, D., Kuo, C. B., Yang, L., Ingleton, P., Luben, R., and Walker, A. M. (1999) Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin, Endocrinology 140, 5087-5094.
3. Ali, S., Pellegrini, I., and Kelly, P. A. (1991) A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor, J. Biol. Chem. 266, 20110-20117.
4. Nagano, M., and Kelly, P. A. (1994) Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction, J. Biol. Chem. 269, 13337-13345.
5. Kelly, P. A., Djiane, J., Postel-Vinay, M. C., and Edery, M. (1991) The prolactin/growth hormone receptor family, Endocr. Rev. 12, 235-251.
6. Lebrun, J. J., Ali, S., Ulrich, A., and Kelly, P. A. (1995) Proline-rich sequence-mediated Jak 2 association to the prolactin receptor is required but not sufficient for signal transduction, J. Biol. Chem. 270, 10664-10670.
7. Ali, S., Edery, M., Pelligrini, I., Lesueur, L., Paly, J., Djiane, J., and Kelly, P. A. (1992) The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter, Mol. Endocrinol. 6, 1242-1248.
8. Goupille, O., Barnier, J. V., Guibert, B., Paly, J., and Djiane, J. (2000) Effect of PRL on MAPK activation: negative regulatory role of the C-terminal part of the PRL receptor, Mol. Cell. Endocrinol. 159, 133-146.
9. Das, R., and Vonderhaar, B. K. (1996) Involvement of SHC, GRB2, SOS, and RAS in prolactin signal transduction in mam-mary epithelial cells, Oncogene 13, 1139-1145.
10. Clevenger, C. V., Rycyzyn, M. A., Syed, F., and Kline, J. B. (2001) Prolactin receptor signal transduction, in Prolactin (Horseman, N., Ed.) pp 355-379, Kluwer Academic Press, Norwell, MA.
11. Chen, T. J., Kuo, C. B., Tsai, K. F., Liu, J. W., Chen, D. Y., and Walker, A. M. (1998) Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone, Endocrinology 139, 609-616.
12. Wang, Y. F., Liu, J. W., Mamidi, M., and Walker, A. M. (1996) Identification of the major site of rat prolactin phosphorylation as serine 177, J. Biol. Chem. 271, 2462-2469.
13. Tuazon, P. T., Lorenson, M. Y., Walker, A. M., and Traugh, J. A. (2002) p21-Activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin, FEBS Lett. 515, 84-88.
14. Wittekind, M., Reizer, J., Deutscher, J., Saier, M. H., and Klevit, R. E. (1989) Common structural changes accompany the functional inactivation of HPr by seryl phosphorylation or by serine to aspartate substitution, Biochemistry 28, 9908-9912.
15. Taverna, D., Groner, B., and Hynes, N. (1999) Epidermal growth factor receptor, platelet-derived growth factor receptor and C-erbB-2 receptor activation all promote growth, but have distinctive effects upon mouse mammary epithelial cell differentiation, Cell Growth Differ. 2, 145-154.
16. Wartmann, M., Cella, N., Hofer, P., Groner, B., Liu, X., Hennighausen, L., and Hynes, N. E. (1996) Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity, J. Biol. Chem. 271, 31863-31868.
17. Rajan, J. V., Wang, M., Marquis, S. T., and Chodosh, L. A. (1996) Brca 2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells, Proc. Natl. Acad. Sci. U.S.A. 93, 13078-13083.
18. Ho, T. W. C., Leong, F. S., Olaso, C. H., and Walker, A. M. (1993) Secretion of specific nonphosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle, Neuroendocrinol. 58, 160-165.
19. Ho, T. W. C., Kawaminami, M., and Walker, A. M. (1993) Secretion of phosphorylated and nonphosphorylated monomer prolactin isoforms during rat pregnancy and pseudopregnancy, Endocrine J. 1, 435-439.
20. Beuvink, I., Hess, D., Flotow, H., Hofsteenge, J., Groner, B., and Hynes, N. E. (2000) Stat 5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity, J. Biol. Chem. 275, 10247-10255.
21. Oetting, W. S., Tuazon, P. T., Traugh, J. A., and Walker, A. M. (1986) Phosphorylation of prolactin, J. Biol. Chem. 26, 1649-1652.
22. Aramburo, C., Montiel, J. L., Proudman, J. A., Berghman, L. R., and Scanes, C. G. (1992) Phosphorylation of prolactin and growth hormone, J. Mol. Endocrinol. 8, 183-191.
23. Kim, B. G., and Brooks, C. L. (1993) Isolation and characterization of phosphorylated bovine prolactin, Biochem. J. 296, 41-47.
24. Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L. M., Montone, K., and Tomaszewski, J. E. (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop, Am. J. Pathol. 146, 695-705.
25. Ellis, L., and Picciano, M. F. (1993) Prolactin variants in term and preterm human milk: altered structural characteristics, biological activity and immunoreactivity, Endocr. Regul. 27, 181-192.
26. Kacsoh, B., Veress, Z., Toth, B. E., Avery, L. M., and Grosvenor, C. E. (1993) Bioactive and immunoreactive variants of prolactin in milk and serum of lactating rats and their pups, J. Endocrinol. 13, 243-257.
27. Kleinberg, D. L., Todd, J., Babitsky, G., and Greising, J. (1982) Estradiol inhibits prolactin induced alpha-lactalbumin production in normal primate mammary tissue in vitro, Endocrinology 110, 279-281.
28. Davis, J. W., Wilkman-Coffelt, J., and Eddington, C. L. (1972) The effect of progesterone on biosynthetic pathways in mammary tissue, Endocrinology 91, 1011-1019.
29. Shemanko, C. S., and Groner, B. (2001) Transcription factors, cofactors and target genes mediating prolactin signals, in Prolactin (Horseman, N, Ed.) pp 381-404, Kluwer Academic Press, Norwell, MA.
30. Zhang, J. J., Blenis, J., Li, H. C., Schindler, C., and Chen-Kiang, S. (1995) Requirement of serine phosphorylation for formation of STAT-promoter complexes, Science 267, 1990-1994.
31. Yamashita, H., Xu, J., Erwin, R. A., Farrar, W. L., Kirken, R. A., and Rui, H (1998) Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells, J. Biol. Chem. 273, 30218-30224.
32. Park, S. H., Yamashita, H., Rui, H., and Waxman, D. J. (2001) Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT 5a) and STAT 5b: impact on STAT 5 transcriptional activity, Mol. Endocrinol. 15, 2157-2171.
33. Yamashita, H., Nevalainen, M. T., Xu, J., LeBaron, M. J., Wagner, K. U., Erwin, R. A., Harmon, J. M., Hennighausen, L., Kirken, R. A., and Rui, H. (2001) Role of serine phosphorylation of Stat 5a in prolactin-stimulated β-casein gene expression, Mol. Cell. Endocrinol. 183, 151-163.
34. Chomczynski, P., Qasba, P., and Topper, Y. J. (1986) Transcriptional and posttranscriptional roles of glucocorticoid in the expression of the rat 25, 000 molecular weight casein gene, Biochem. Biophys. Res. Commun. 134, 812-818.
35. Houdebine, L. M., Devinoy, E., and Delouis, C. (1978) Stabilization of casein mRNA by prolactin and glucocorticoids, Biochimie 60, 57-63.
36. Poyet, P., Henning, S. J., and Rosen, J. M. (1989) Hormonedependent beta-casein mRNA stabilization requires ongoing protein synthesis, Mol. Endocrinol. 3, 1961-1968.
37. Berlanga, J. J., Garcia-Ruiz, J. P., Perrot-Applanat, M., Kelly, P. A., and Edery, M. (1997) The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter, Mol. Endocrinol. 11, 1449-1457.
38. Binart, N., Imbert-Bollore, P., Baran, N., Viglietta, C., and Kelly, P. A. (2003) A short form of the prolactin receptor is able to rescue mammopoiesis in heterozygous prolactin receptor mice, Mol. Endocrinol, (in press).
39. Telleria, C. M., Parmer, T. G., Zhong, L., Clarke, D. L., Albarracin, C. T., Duan, W. R., Linzer, D. I., and Gibori, G. (1997) The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy, Endocrinology 138, 4812-4820.